Suppression of anti-tumour leukocytes at metastatic target sites by myeloid cells may be mediated through several mechanisms, including via increased production of inducible nitric oxide synthase (iNOS) or reactive oxygen species (ROS) (Li et al, 2020a; Li et al, 2020b). Here, NOS2 is linked to neoplasm.